Pharmaceutical Supply Chain Strategies: Reassessing Product Distribution to Cut Costs and Improve Supply Chain Management - Market Research Reports

Welcome - Home - Register - Login - Help/FAQ - 0 items

Search
Enter keywords, a title or
a report id number below.

Advanced


	Select a currency for use throughout the site

Viewing report

Order by Fax
Printer Friendly
PDF Brochure
Send to Friend
Enquire before Buying

| More

Hard Copy
Electronic

Pharmaceutical Supply Chain Strategies: Reassessing Product Distribution to Cut Costs and Improve Supply Chain Management
Datamonitor, March 2008, Pages: 64



		Description



		Table of Contents


	Companies Mentioned



		Enquire before Buying



		Send to a Friend

Alliance Boots Plc
AstraZeneca PLC
Cardinal Health, Inc.
Eli Lilly and Company
GlaxoSmithKline Plc
Graham Packaging Holdings Company
Medco Health Solutions Inc
Merck & Co., Inc.
Novartis AG
Pfizer Inc
Walgreen Co.
Wal-Mart Stores, Inc.

Customers who bought this item also bought

Impact of Counterfeits on Parallel Trade & Pharmaceutical Distribution: Issues, Initiatives and Insights for Supply Chain Integrity

Filling the Holes in the Drug Supply Chain (Strategic Focus)

How to React to Parallel Trade

Supply Chain Management in Pharmaceutical Industry in Poland 2008

Supply Chain Management in Pharmaceutical Industry in Poland 2008

Supply Chain in the Pharmaceutical Industry

Parallel Trade in Europe and the US: The Challenges Facing Pharma

The Pharmaceutical Parallel Trade Outlook: Challenges To Pharmaceutical Companies Across Europe And The US

European Patient Safety and Parallel Pharmaceutical Trade - A Potential Public Health Disaster?

Technology Across the Supply Chain

Prescription Drug Counterfeiting

Guide to the Carbon Efficient Supply Chain

Top of page